Jason Butler
Stock Analyst at Citizens JMP
(4.82)
# 462
Out of 4,509 analysts
759
Total ratings
51.4%
Success rate
18.1%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZVRA Zevra Therapeutics | Maintained: Buy | $18 → $25 | $13.18 | +89.68% | 10 | Jun 9, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $4.74 | +132.07% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $131 → $187 | $135.98 | +37.52% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Maintained: Buy | $42 → $39 | $25.35 | +53.85% | 24 | May 15, 2026 | |
| PGEN Precigen | Maintained: Buy | $9 → $11 | $5.17 | +112.77% | 49 | May 14, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | $62 → $55 | $18.91 | +190.85% | 3 | May 14, 2026 | |
| PRTA Prothena Corporation | Maintained: Buy | $19 → $20 | $8.83 | +126.50% | 27 | May 8, 2026 | |
| NERV Minerva Neurosciences | Initiated Coverage: Buy | $14 | $4.27 | +227.87% | 19 | Apr 15, 2026 | |
| NSRX Nasus Pharma | Maintained: Buy | $19 → $18 | $3.08 | +484.42% | 2 | Mar 26, 2026 | |
| ARGX argenx SE | Maintained: Buy | $699 → $944 | $876.25 | +7.73% | 42 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $35 | $25.50 | +37.25% | 48 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $10 | $4.21 | +137.53% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $96 | $82.24 | +16.73% | 62 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $6.10 | +211.48% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $77 → $80 | $40.59 | +97.09% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 → $92 | $76.11 | +20.88% | 48 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $12 | $4.06 | +195.57% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.18 | +25.79% | 49 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $8.32 | +164.42% | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.76 | n/a | 34 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $38 | $18.99 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.011 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.20 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.25 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.23 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.43 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €369.63 | $756.80 | n/a | 1 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $70 | $82.84 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.73 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.18 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.00 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $2.93 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $334.15 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.04 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $47.49 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $12.62 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.87 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.08 | n/a | 1 | Mar 26, 2013 |
Zevra Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: $18 → $25
Current: $13.18
Upside: +89.68%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $4.74
Upside: +132.07%
ABIVAX Société Anonyme
Jun 2, 2026
Maintained: Buy
Price Target: $131 → $187
Current: $135.98
Upside: +37.52%
GH Research
May 15, 2026
Maintained: Buy
Price Target: $42 → $39
Current: $25.35
Upside: +53.85%
Precigen
May 14, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $5.17
Upside: +112.77%
Avalo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $18.91
Upside: +190.85%
Prothena Corporation
May 8, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $8.83
Upside: +126.50%
Minerva Neurosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.27
Upside: +227.87%
Nasus Pharma
Mar 26, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $3.08
Upside: +484.42%
argenx SE
Feb 27, 2026
Maintained: Buy
Price Target: $699 → $944
Current: $876.25
Upside: +7.73%
Feb 26, 2026
Maintained: Buy
Price Target: $38 → $35
Current: $25.50
Upside: +37.25%
Feb 26, 2026
Maintained: Buy
Price Target: $8 → $10
Current: $4.21
Upside: +137.53%
Feb 25, 2026
Maintained: Buy
Price Target: $88 → $96
Current: $82.24
Upside: +16.73%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $6.10
Upside: +211.48%
Nov 7, 2025
Maintained: Buy
Price Target: $77 → $80
Current: $40.59
Upside: +97.09%
Nov 4, 2025
Maintained: Buy
Price Target: $91 → $92
Current: $76.11
Upside: +20.88%
Oct 9, 2025
Maintained: Buy
Price Target: $9 → $12
Current: $4.06
Upside: +195.57%
Sep 22, 2025
Reiterated: Buy
Price Target: $4
Current: $3.18
Upside: +25.79%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $8.32
Upside: +164.42%
May 12, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.76
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $42 → $38
Current: $18.99
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.011
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.20
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $17.25
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.23
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.43
Upside: n/a
Feb 1, 2021
Maintained: Buy
Price Target: €369.63
Current: $756.80
Upside: n/a
Jan 9, 2020
Maintained: Buy
Price Target: $58 → $70
Current: $82.84
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.73
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.18
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $6.00
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $2.93
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $334.15
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $4.04
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $47.49
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $12.62
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $12.87
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $2.08
Upside: n/a